Stock A106190 HIGH TECH PHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company High Tech Pharm Co., Ltd.

Equities

A106190

KR7106190002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
9,980 KRW +5.83% Intraday chart for High Tech Pharm Co., Ltd. +3.21% +6.97%
2023 High Tech Pharm Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 High Tech Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Business Summary

HIGH TECH PHARM. CO., LTD. is a Korea-based company mainly engaged in the manufacture of antibiotic pharmaceutical ingredients for injections. The Company's products include sterile imipenem, sterile cilastatin sodium, sterile blended imipenem and cilastatin sodium, injectable sterile meropenem, injectable sterile panipenem, faropenem and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 65

Sales per Business

KRW in Million2022Weight2023Weight Delta
Antibiotic Drugs Product
68.9 %
52,465 51.0 % 52,876 68.9 % +0.78%
Antibiotic Drugs Merchandise
30.5 %
49,447 48.0 % 23,382 30.5 % -52.71%
Transportation
0.7 %
1,035 1.0 % 514 0.7 % -50.36%

Sales per region

KRW in Million2022Weight2023Weight Delta
Italy
95.8 %
99,589 96.7 % 73,550 95.8 % -26.15%
Taiwan
1.6 %
609 0.6 % 1,239 1.6 % +103.51%
Brazil
1.4 %
1,340 1.3 % 1,100 1.4 % -17.94%
Others
1.1 %
1,072 1.0 % 874 1.1 % -18.46%
South Korea
0.0 %
337 0.3 % 9 0.0 % -97.20%

Managers

Managers TitleAgeSince
Jeong-Soo Kim CEO
 Chief Executive Officer 65 -
In-Cheol Kim BRD
 Director/Board Member 56 16-03-24
Young-Hoon Kim BRD
 Director/Board Member 59 -

Members of the board

Members of the board TitleAgeSince
Jeong-Soo Kim CEO
 Chief Executive Officer 65 -
Young-Hoon Kim BRD
 Director/Board Member 59 -
In-Cheol Kim BRD
 Director/Board Member 56 16-03-24
Ik-Hwan Jang BRD
 Director/Board Member 71 19-03-28
Sung-Jae Ko BRD
 Director/Board Member 46 -
Byung-Guk Ko BRD
 Director/Board Member 60 -
Gwan-Seong Kim BRD
 Director/Board Member 65 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,633,173 5,831,943 ( 54.85 %) 0 54.85 %

Shareholders

NameEquities%Valuation
INTESA SANPAOLO S.P.A.
39.57 %
4,207,500 39.57 % 32 M ₩
Marco Falciani
2.962 %
315,000 2.962 % 2 M ₩
Jeong-Soo Kim
2.551 %
271,230 2.551 % 2 M ₩
Jin Heo
0.0707 %
7,515 0.0707 % 56 603 ₩
Jong-oh Woo
0.0564 %
6,000 0.0564 % 45 192 ₩
Deok-geun Choi
0.0169 %
1,800 0.0169 % 13 558 ₩
Young-Hoon Kim
0.0141 %
1,500 0.0141 % 11 298 ₩
Jin-yong Park
0.008887 %
945 0.008887 % 7 118 ₩
Chang-woo Han
0.007053 %
750 0.007053 % 5 649 ₩

Company contact information

HIGH TECH PHARM Co., Ltd.

12 Cheomdansaneop 6-ro Daesowon-myeon

27466, Chungju-si

+

http://www.htpharm.com
address High Tech Pharm Co., Ltd.(A106190)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
HIGH TECH PHARM CO., LTD. Stock High Tech Pharm Co., Ltd.
+6.97% 76.71M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.40% 44.1B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+17.11% 21.97B
CIPLA LIMITED Stock Cipla Limited
+8.10% 13.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+6.06% 13.22B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+35.95% 11.36B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.53% 7.07B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+10.09% 5.23B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A106190 Stock
  4. Company High Tech Pharm Co., Ltd.